Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James D Berry

Showing results (1-10 of 176) with videos related to

Pageof 18
Sort By:
Muscle & Nerve|August 30, 2025
Cardiac Troponin T in Tofersen-Treated SOD1 ALS Patients: Beginning to Resolve the Catch-22 of Identifying Treatment Responsive Biomarkers in ALS Drug DevelopmentJames D Berry, Robert Bowser
Neurology|January 11, 2019
Heterogeneity, urgency, generalizability, and enrollment: The HUGE balance in ALS trialsChafic Karam, James D Berry
Neurology|April 15, 2014
Reevaluating the risk of DVT in people with ALS: weak in the knees and DVTsJames D Berry, Lawrence Korngut
Neurology|August 10, 2005
A single dose of gabapentin reduces acute pain and allodynia in patients with herpes zosterJames D Berry, Karin Lottrup Petersen
The Journal of Clinical Psychiatry|December 21, 2023
The Intense Psychological Burden of ALS, the Enduring Strength of People Living With ALS, and the Tools We Can Use to HelpDoreen T Ho, James D Berry
Clinical Investigation|May 1, 2012
New considerations in the design of clinical trials for amyotrophic lateral sclerosisJames D Berry, Merit E Cudkowicz
Clinical Investigation|February 17, 2017
Outcome measures in amyotrophic lateral sclerosis clinical trialsSabrina Paganoni, Merit Cudkowicz, James D Berry
JAMA|June 18, 2025
CNM-Au8 in Amyotrophic Lateral Sclerosis-ReplyJames D Berry, Nicholas Maragakis, Sabrina Paganoni
Muscle & Nerve|February 7, 2026
Survival of Intravenous Edaravone-Treated Patients With ALS: Evidence From Administrative Claims AnalysesBenjamin Rix Brooks, James D Berry, Malgorzata Ciepielewska
Seminars in Neurology|October 28, 2015
Amyotrophic Lateral Sclerosis: ReviewJohnny S Salameh, Robert H Brown, James D Berry
Pageof 18

Showing results (1-10 of 176) with videos related to

Sort By:
Pageof 18
Muscle & Nerve|August 30, 2025
Cardiac Troponin T in Tofersen-Treated SOD1 ALS Patients: Beginning to Resolve the Catch-22 of Identifying Treatment Responsive Biomarkers in ALS Drug DevelopmentJames D Berry, Robert Bowser
Neurology|January 11, 2019
Heterogeneity, urgency, generalizability, and enrollment: The HUGE balance in ALS trialsChafic Karam, James D Berry
Neurology|April 15, 2014
Reevaluating the risk of DVT in people with ALS: weak in the knees and DVTsJames D Berry, Lawrence Korngut
Neurology|August 10, 2005
A single dose of gabapentin reduces acute pain and allodynia in patients with herpes zosterJames D Berry, Karin Lottrup Petersen
The Journal of Clinical Psychiatry|December 21, 2023
The Intense Psychological Burden of ALS, the Enduring Strength of People Living With ALS, and the Tools We Can Use to HelpDoreen T Ho, James D Berry
Clinical Investigation|May 1, 2012
New considerations in the design of clinical trials for amyotrophic lateral sclerosisJames D Berry, Merit E Cudkowicz
Clinical Investigation|February 17, 2017
Outcome measures in amyotrophic lateral sclerosis clinical trialsSabrina Paganoni, Merit Cudkowicz, James D Berry
JAMA|June 18, 2025
CNM-Au8 in Amyotrophic Lateral Sclerosis-ReplyJames D Berry, Nicholas Maragakis, Sabrina Paganoni
Muscle & Nerve|February 7, 2026
Survival of Intravenous Edaravone-Treated Patients With ALS: Evidence From Administrative Claims AnalysesBenjamin Rix Brooks, James D Berry, Malgorzata Ciepielewska
Seminars in Neurology|October 28, 2015
Amyotrophic Lateral Sclerosis: ReviewJohnny S Salameh, Robert H Brown, James D Berry
Pageof 18